SKHCF (Sonic Healthcare) FFO


SKHCF Sonic Healthcare Ltd SKHCF
68 GF Score
Price $12.76
GF Value $22.27
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sonic Healthcare FFO?

FFO (Funds from operations) only applies to REITs.

SKHCF
68GF Score
Sonic Healthcare Ltd SKHCF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sonic Healthcare (SKHCF) Overvalued in 2026?

Based on GuruFocus' analysis, Sonic Healthcare stock appears to be undervalued. The current stock price of $12.76 is trading 42.7% below its estimated GF Value™ of $22.27. GuruFocus considers Sonic Healthcare to be Significantly Undervalued.

Key valuation signals for SKHCF:

  • FFO:
  • GF Value™: $22.27 vs. price of $12.76 (42.7% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the SKHCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sonic Healthcare Business Description

Address 225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
68GF Score

Get the complete analysis for SKHCF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.76
Price
$22.27
GF Value